|
|||
|
Multiple Sclerosis Info
If you want this blog to continue, than make it financialy viable for Bonnie to continue it. She puts in 2-3 hours a day into this blog, and spends money on it for it's upkeep.
Search
This Month
|
Friday, May 12
by
All About MS
on Fri 12 May 2006 10:54 AM CST
A new way to preserve the cells that surround and protect nerves could lead to new treatments for demyelinating diseases such a multiple sclerosis, a research team reports more »
by
All About MS
on Fri 12 May 2006 01:00 AM CST
Oral Presentation at American Academy of Neurology CARLSBAD, C.A. --
The Immune Response Corporation (OTCBB:IMNR.OB)
announced that its T-cell receptor peptide vaccine candidate,
NeuroVax™, induces increased FOXP3 expression resulting in re-
establishment of normal levels of the FOXP3+ regulatory T-cells
believed to be important in controlling the development of multiple
sclerosis (MS). Results of the recently completed open-label trial more »
by
All About MS
on Fri 12 May 2006 12:00 AM CST
New data from a phase 2 study of FTY720, (fingolimod) show a better than 50% reduction in the annualized relapse rate in patients with relapsing- remitting multiple sclerosis (MS). The results were more »
|
||